The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Open accessAbstract
Background Neurofibrillary pathology has a stereotypical progression in Alzheimer's disease (AD) that is encapsulated in the Braak staging scheme; however, some AD cases are atypical and do not fit into this scheme. We aimed to compare clinical and neuropathological features between typical and atypical AD cases.Methods AD cases with a Braak neurofibrillary tangle stage of more than IV were identified from a brain bank database. By use of thioflavin-S fluorescence microscopy, we assessed the density and the distribution of neurofibrillary tangles in three cortical regions and two hippocampal sectors. These data were used to construct an algorithm to classify AD cases into typical, hippocampal sparing, or limbic predominant. Classified cases were then compared for clinical, demographic, pathological, and genetic characteristics. An independent cohort of AD cases was assessed to validate findings from the initial cohort.Findings 889 cases of AD, 398 men and 491 women with age at death of 37-103 years, were classified with the algorithm as hippocampal sparing (97 cases [11%]), typical (665 [75%]), or limbic predominant (127 [14%]). By comparison with typical AD, neurofibrillary tangle counts per 0.125 mm(2) in hippocampal sparing cases were higher in cortical areas (median 13, IQR 11-16) and lower in the hippocampus (7.5, 5.2-9.5), whereas counts in limbic-predominant cases were lower in cortical areas (4.3, 3.0-5.7) and higher in the hippocampus (27, 22-35). Hippocampal sparing cases had less hippocampal atrophy than did typical and limbic-predominant cases. Patients with hippocampal sparing AD were younger at death (mean 72 years [SD 10]) and a higher proportion of them were men (61 [63%]), whereas those with limbic-predominant AD were older (mean 86 years [SD 6]) and a higher proportion of them were women (87 [69%]). Microtubule-associated protein tau (MAPT) H1H1 genotype was more common in limbic-predominant AD (54 [70%]) than in hippocampal sparing AD (24 [46%]; p=0.011), but did not differ significantly between limbic-predominant and typical AD (204 [59%]; p=0.11). Apolipoprotein E (APOE) ɛ4 allele status differed between AD subtypes only when data were stratified by age at onset. Clinical presentation, age at onset, disease duration, and rate of cognitive decline differed between the AD subtypes. These findings were confirmed in a validation cohort of 113 patients with AD.Interpretation These data support the hypothesis that AD has distinct clinicopathological subtypes. Hippocampal sparing and limbic-predominant AD subtypes might account for about 25% of cases, and hence should be considered when designing clinical, genetic, biomarker, and treatment studies in patients with AD.Funding US National Institutes of Health via Mayo Alzheimer's Disease Research Center, Mayo Clinic Study on Aging, Florida Alzheimer's Disease Research Center, and Einstein Aging Study; and State of Florida Alzheimer's Disease Initiative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“clinical features lack specificity for a pathologic process, but rather indicate brain regions or systems affected by the disease process [3, 4].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three major subtypes of AD can be classified by the relative density of hippocampal neurofibrillary tangles with respect to neocortical tangles [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Genetic analyses of APOE suggest APOE4 is more closely linked to typical or limbic predominant than hippocampal sparing AD [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Nonamnestic clinical presentations, that is, language, visuospatial, and executive disorders, may also be due to AD [63–66].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [65]
In the citing paper
“Another challenge of CPC studies is that the molecular, anatomic, and clinical changes of AD may not progress in a uniform fashion (7, 12-15).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“and that not all AD cases fall within the same spatial continuum with regard to brain NFT distributions (12, 15, 151).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“Nevertheless, Braak staging also masks the fact that marked variability in pathologic lesion density across cases exists within a given Braak stage (7, 12)”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Self-citationAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationBarker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
Self-citation
Cited by
Sorted by citations
Items 801–900 of 971
Wang, M., Wu, H., Bonner‐Jackson, A., Chen, Y., Tang, W., Feng, H., Zhang, L., Chen, C., Leverenz, J. B., & Pillai, J. A. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000055 · Cited by 1
Huang, Y., Xu, J., Fan, Z., Hu, Y., He, X., Chen, A., Liu, Y., Yin, R., Guo, J., DeKosky, S. T., et al. (2026) · Journal of Healthcare Informatics Research · doi:10.1007/s41666-026-00230-2 · Cited by 1
Yang, F., Maher, M., Saxena, R., & Dutta, J. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1151 · Cited by 1
Greater locus coeruleus vulnerability in atypical clinicopathologic forms of Alzheimer's disease
Dunlop, S. R., Matchett, B. J., Mannsbart, A., Al‐Shaikh, F. S. H., Peng, Z., Rothberg, D. M., Tranovich, J. F., Duara, R., Vélez-Uribe, I., Gondrez, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71140 · Cited by 1
Self-citationOno, D., Kondrakunta, S., Mak, E., Przybelski, S. A., Fought, A. J., Schwarz, C. G., Murray, M. E., Nguyen, A. T., Reichard, R. R., Senjem, M. L., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02991-x · Cited by 1
Self-citationShir, D., Corriveau‐Lecavalier, N., Jones, D. T., Ramanan, V. K., Lachner, C., Knopman, D. S., Petersen, R. C., Josephs, K. A., Day, G. S., Graff‐Radford, J., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218347 · Cited by 1
Self-citationFunctional heterogeneity across structural MRI-based atrophy subtypes in Alzheimer’s disease
Xu, D., Zhang, H., Piao, Z., He, Y., Li, H. Y., & Zhang, N. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100255 · Cited by 1
Stover, K. R. (2015) · DalSpace (Dalhousie University) · Cited by 1
Diagnostic précoce de la maladie d’Alzheimer
Saint‐Aubert, L., Puel, M., Chollet, F., & Pariente, J. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.006 · Cited by 4
Diagnostic de la maladie d’Alzheimer
Démonet, J. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_1 · Cited by 1
Advances in Alzheimer’s Disease Management
Gauthier, S. G., & Rosa‐Neto, P. (2012) · doi:10.2217/9781780840840 · Cited by 1
Stover, K. R. (2012) · Library and Archives Canada (Government of Canada) · Cited by 1
Mangone, C. A., Escalante, N. P., Gigena, V., de Pascale, A. M., Olguín, J. M., Amoedo, I. L., Arnaboldi, A., Genovese, O., Dorman, G. S., Caches, M. A., et al. (2017) · Neurología Argentina · doi:10.1016/j.neuarg.2017.06.001 · Cited by 1
A Neurologist's Practical Approach to Cognitive Impairment
Tipton, P. W., Day, G. S., & Graff‐Radford, N. R. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726354 · Cited by 2
Self-citationTraits and Trammels of Tau Tracer Imaging
Villemagne, V. L., Lopresti, B. J., Doré, V., Minhas, D. S., Gogola, A., Nadkarni, N. K., Mason, N. S., Bourgeat, P., López, O. L., Ikonomović, M. D., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_6 · Cited by 1
Ramírez-Salazar, S. A., MacRae, C., Feany, M. Β., Miller, M. B., Yang, H., Meadows, M., McGinnis, S. M., Silbersweig, D., Gale, S. A., & Daffner, K. R. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230097 · Cited by 2
Nguyen, M., Pham, B. H., Toi, V. V., & Ha, H. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100093 · Cited by 1
Cognitive Aging and the Transition to Early Alzheimer’s Disease
Mormino, E. C., & Jagust, W. J. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190917982.013.59 · Cited by 1
Doganyigit, B., Defrancesco, M., Schurr, T. A., Steiger, R., Gizewski, E. R., Mangesius, S., Galijašević, M., Hofer, A., & Tuovinen, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1485620 · Cited by 1
Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
Frings, L., Hellwig, S., Brumberg, J., Rau, A., Mix, M. D., Blazhenets, G., Urbach, H., & Meyer, P. T. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70142 · Cited by 1
Chettupalli, A. K., Gupta, N., Bukke, S. P. N., Singh, M. P., & Mandal, C. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118803 · Cited by 1
Differential Patterns of Dysfunction in Neurodegenerative Dementias
Salmon, É. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00070-1 · Cited by 1
Alzheimer's Disease: Current Clinical and Neuropathologic Diagnostic Criteria
Ka, J. (2014) · Cited by 1
Mild Cognitive Impairment and Early Dementia
Damasceno, B. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-57267-9_20 · Cited by 1
On Hippocampus Associative Modeling by Approximating Nonlinear Kullback-Leibler Sparsity Constraint
Ghosh, S., Chandra, A., & Mudi, R. (2021) · International Conference on Computer Communication and Informatics (ICCCI) · doi:10.1109/iccci50826.2021.9402467 · Cited by 1
Lin, L., Zhang, G., Zhang, B., & Wu, S. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202125302095 · Cited by 1
The diagnosis of Alzheimer’s disease: assessment and criteria
Dubois, B., Filippi, M., & Waldemar, G. (2017) · doi:10.1093/med/9780198701590.003.0126 · Cited by 1
I. Demenz: Medizinische Aspekte
Knell, S., Thal, D. R., & Lipp, V. (2022) · Verlag Karl Alber eBooks · doi:10.5771/9783495999370-17
Ellison, D., Love, S., Chimelli, L. M. C., Harding, B. N., Lowe, J. S., Vinters, H. V., Brandner, S., & Yong, W. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3515-0.00031-3 · Cited by 1
Remoli, G., Tariciotti, L., Remore, L. G., Palmisciano, P., Sciancalepore, F., Canevelli, M., Lacorte, E., Re, F. D., Bruno, G., Ferrarese, C., et al. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06821-w · Cited by 1
Modelling the Neuroanatomical Progression of Alzheimer's Disease and Posterior Cortical AtrophyPreprint
Marinescu, R. V. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2003.04805 · Cited by 1
Towards harmonizing subtyping methods for neuroimaging studies in Alzheimer’s diseasePreprint
Mohanty, R., Mårtensson, G., Poulakis, K., Muehlboeck, J., Rodriguez‐Vieitez, E., Chiotis, K., Grothe, M. J., Nordberg, A. K., Ferreira, D., & Westman, E. (2020) · medRxiv · doi:10.1101/2020.04.19.20064881 · Cited by 1
Groot, C., Grothe, M. J., Mukherjee, S., Jelistratova, I., Jansen, I. E., van Loenhoud, A. C., Risacher, S. L., Saykin, A. J., Donald, C. L. M., Mez, J. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.04.235762 · Cited by 1
Mohanty, R., Ferreira, D., Nordberg, A. K., Westman, E., & Initiative, T. A. D. N. (2021) · medRxiv · doi:10.1101/2021.08.10.21261824 · Cited by 1
Shatz, R. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_915 · Cited by 1
Differential response to Donepezil in MRI subtypes of mild cognitive impairmentPreprint
Diaz‐Galvan, P., Lorenzon, G., Mohanty, R., Mårtensson, G., Cavedo, E., Lista, S., Vergallo, A., Kantarci, K., Hampel, H. J., Dubois, B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2485451/v1 · Cited by 1
Tau-PET abnormality change along with Alzheimer’s disease: a topological perspectivePreprint
Ding, J., Shen, C., Wang, Z., Yang, Y., Fakhri, G. E., Lu, J., Liang, D., Zheng, H., Zhou, Y., & Sun, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2756518/v1 · Cited by 1
Gebre, R. K., Moscoso, A., Raghavan, S. K., Wiste, H. J., Sparrman, K. J., Heeman, F., Costoya‐Sánchez, A., Schwarz, C. G., Spychalla, A. J., Lowe, V. J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3290598/v1 · Cited by 1
Self-citationEditorial: New insights into atypical Alzheimer's disease: from clinical phenotype to biomarkers
Singh, N. A., & Sintini, I. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1414443 · Cited by 1
Pathologic subtyping of Alzheimer’s disease brain tissue reveals disease heterogeneityPreprint
Lam, T. G., Ross, S. K., Ciener, B., Xiao, H., Flaherty, D., Lee, A., Dugger, B. N., Reddy, H., & Teich, A. F. (2024) · medRxiv · doi:10.1101/2024.10.14.24315458 · Cited by 1
Neuronal activity and amyloid-β cause tau seeding in the entorhinal cortex in Alzheimer’s diseasePreprint
Alexandersen, C. G., Bassett, D. S., Goriely, A., Chaggar, P., & Initiative, T. A. D. N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642054 · Cited by 1
Kinreich, S., Bingly, A., & Pandey, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.09.653177 · Cited by 1
Venkatraghavan, V., Klein, S., Fani, L., Ham, L. S., Vrooman, H. A., Ikram, M. K., Niessen, W. J., & Bron, E. E. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117646
Josephs, K. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00080-4
Berntzon, L. (2015) · DiVA (Stockholm University)
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Dementie, meer dan MMSE en casemanager!
DAUTZENBERG, P. L. J. (2012) · Huisarts en Wetenschap · doi:10.1007/s12445-012-0169-5
Abner, E. L. (2013) · UKnowledge (University of Kentucky)
Kovács, G. G. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.008
Vemuri, P., Murray, M. E., & Jack, C. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00010-3
Self-citationInteraction between cerebral small vessel disease and neurodegenerative changes
van der Flier, W. M., & Kalaria, R. N. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.025
Section summary and perspectives: Translational medicine in neurology
Barrett, J. E., & Coyle, J. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.015
Iwasaki, Y., Deguchi, A., Mori, K., Ito, M., Mimuro, M., & Yoshida, M. (2016) · Psychogeriatrics · doi:10.1111/psyg.12198
Dementia and Singing: A Conversation Analysis case study of singing in everyday interaction
Foster, R. M. G. L. W. (2015) · CU Scholar (University of Colorado Boulder)
Alzheimer's disease as a neuropathological continuum in clinical practice.
Sheardová, K., Hudeček, D., Hromková, O., Marciniak, R., & Hort, J. (2016) · Neurologie pro praxi · doi:10.36290/neu.2016.063
Diagnosis of Alzheimer’s disease
Rosa‐Neto, P., Rowley, J., Leuzy, A., Mohades, S., Shin, M., Dauar, M. T., & Gauthier, S. G. (2012) · doi:10.2217/ebo.12.66
Voevodskaya, O. (2018) · Figshare
Hansson, K. (2018) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Aging, cognitive ability and the risk of dementia in the Helsinki Birth Cohort Study
Rantalainen, V. (2019) · Työväentutkimus Vuosikirja
Shafiq, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7266
Patel, S. (2019) · TSpace (University of Toronto)
Traitement de la maladie d’Alzheimer : une lueur au bout du tunnel ?
Pariente, J., Rafiq, M., Bénaiteau, M., Gouilly, D., Pomies, E., Jasse, L., Drif, A., Calvas, F., Payoux, P., Rascol, O., et al. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.12.003
Study of early stages of Alzheimer's disease using magnetic resonance imaging
Casamitjana, A. (2019) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-175259
Modelling prognostic trajectories in Alzheimer’s disease
Giorgio, J. (2020) · Apollo (University of Cambridge) · doi:10.17863/cam.58841
Shinohara, M., Hirokawa, J., Shimodaira, A., Tashiro, Y., Suzuki, K., Fukumori, A., Matsubara, T., Morishima, M., Saito, Y., Murayama, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-149164/v1
Transcriptome Meta-Analysis Suggests the Existence of Two Molecular Subtypes in Alzheimer’s DiseasePreprint
Nazari, A., Marashi, S., & Montazeri, H. (2021) · Research Square · doi:10.21203/rs.3.rs-466388/v1
Genetic analyses of SERPINA5 in Alzheimer’s diseasePreprint
Matchett, B. J., Lincoln, S., Baker, M. C., Tamvaka, N., Cabrera-Rodriguez, J. N., Labuzan, S. A., Helminger, J., Hinkle, K. M., Duara, R., Graff‐Radford, N. R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-769744/v1
Self-citationFricke, M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8687
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Shatz, R. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-56782-2_915-3
Perani, D. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727195707.793537453
Cappa, S. F. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734240725.793553189
Stephen, T., Korobkova, L., Breningstall, B. M., Nguyen, K., Mehta, S., Pachicano, M., Jones, K. T., Hawes, D., Cabeen, R. P., & Bienkowski, M. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.31.543117
Yi, F., Zhang, Y., Yuan, J., Liu, Z., Zhai, F., Hao, A., Wu, F. Q., Somekh, J., Mor Peleg, B., Zhu, Y., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4495147
Bednorz, A., & Derejczyk, J. (2023) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2023.129074
Varghese, R., Digholkar, G., Deshpande, A., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010013 · Cited by 1
He, X., Wu, B., Kuo, K., Zhang, W., Ma, Q., Xiang, S., Li, Y., Wang, Z.-Y., Dong, Q., Feng, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23512817
Towards in vivo MRI-based diagnostics and tracking of dementia
Ortega‐Cruz, D. (2024) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.81334
Reyes, I., Faustin, A., Tian, C., & Masurkar, A. V. (2024) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230113
Wei, S., Wen, C., Tan, H., & Wei, C. (2024) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn60899.2024.10650102
Clinical Diagnosis of Alzheimer’s Disease
Güleç, Z. E. K., & Bozluolçay, M. (2024) · doi:10.69860/nobel.9786053359166.5
Adaptive Subtype and Stage Inference for Alzheimer’s Disease
Wang, X., & Shi, Y. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-72384-1_5
Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers
Naiyeri, A., Moqadami, A., & Khalaj‐Kondori, M. (2025) · Current Gene Therapy · doi:10.2174/0115665232338503241227111640
Ruíz-Vanoye, J. A., Díaz-Parra, O., Márquez-Vera, M. A., Barrera-Cámara, R. A., Fuentes-Penna, A., Simancas-Acevedo, E., Ruiz-Jaimes, M. Á., Xicotencatl-Perez, J. M., & Ramos-Fernandez, J. C. (2025) · Symmetry · doi:10.3390/sym17020172
Transforming Alzheimer's Treatment: Unveiling New Potential with Drug Repurposing Strategies
Mishra, A. S., Vasanthan, M. V. M., Ghosh, B., & Sivakumar, P. M. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673341391241231054936
Vilor‐Tejedor, N., Rodrigo, A., Genius, P., Rodríguez‐Fernández, B., Anastasi, F., Pelkmans, W., Navarro, A., Adams, H. H. H., Wisse, L. E. M., Gispert, J. D., et al. (2025) · medRxiv · doi:10.1101/2025.03.25.25324619
Nguyen, M., Dương, N. T., Duc, V. T., Phan, C., Phan, T. N. M., & Ha, H. (2025) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-90194-2_29
The Relationship between Age and Cognitive Subtypes of Alzheimer Syndrome and Related Dementias
Lima, B. S., Binns, M. A., Black, S. E., Freedman, M., Kumar, S., Lahiri, D., Roncero, C. T., Strother, S. C., Tang‐Wai, D. F., Tartaglia, M. C., et al. (2025) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000547124
Imaging Markers of Amyloid and Tau in Alzheimer Disease
Tarawneh, R. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_20
The Psychopathology and Neuropsychology of Alzheimer’s Disease: A New Narrative
Barakat, M., Annan, I., Sader, A., & Khoury, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_54
Tau-Connectome Subtypes and Solanezumab Response in Preclinical Alzheimer’s DiseasePreprint
Abuwarda, H., Tsai, W., Ding, S., Elhassan, M. O. E., Shen, X., Zhao, Y., Constable, R. T., & Fredericks, C. A. (2025) · medRxiv · doi:10.1101/2025.09.13.25335690
takaliuang, D. S., Muljadi, R., Sutanto, R., & Situmeang, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7953365/v1
Metadata
- Authors
- Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W.
- Affiliations
- Mayo Clinic (US)
- Mount Sinai Medical Center (US)
- Corresponding author
- Dickson, Dennis W
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 10
- Issue
- 9
- Pages
- 785-796
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC3175379
- OpenAlex
- W2075444764
- Cited by
- 972
- References
- 44
- Citations by year
- 2026: 60 · 2025: 80 · 2024: 78 · 2023: 96 · 2022: 80 · 2021: 104 · 2020: 70 · 2019: 73 · 2018: 56 · 2017: 50 · 2016: 55 · 2015: 37 · 2014: 36 · 2013: 54 · 2012: 35
- FWCI
- 29.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health
- National Institute on Aging (P50‐AG16574, U01AG06786, P50 AG215711, P01AG03949, U01AG006786, P01AG003949, R21AG038736, P50AG025711, P01AG017216, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P50NS072187)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, Braak staging, hippocampal sparing, hippocampal atrophy, tau pathology, clinical features, atypical Alzheimer's disease, sex differences, age at death, genetic risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Limbic System, Male, Middle Aged, Retrospective Studies, Cohort Studies, Neurofibrillary Tangles, tau Proteins, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
